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INTRODUCTION
Nuclear protein in testis (NUT), i.e., NUT midline carcinomas (NMCs) are malignant epithelial tumors that have chromosomal rearrangements of the gene encoding NUT at 15 to other genes, usually BRD4 on 19 and other protein-like BRD3 and NSD3, creating chimeric genes that encode BRD-NUT fusion proteins, which leads to proliferation of immature neoplastic cells and blocking of squamous differentiation. [1] [2] [3] [4] NMCs mostly arises in younger patients but has been reported in a wide range of ages from newborns to the elderly (0-78 years). [5] Most cases were reported in midline structures such as mediastinum, thymus, and head and neck, but other sites are also reported. [6, 7] Histologically, it is undifferentiated epitheloid cells with variable focal squamous differentiation. It is necessary to differentiate it from other carcinoma, as it is metastatically aggressive carcinoma, treatment of which is not defined. There is no effective guideline or current approach to treatments. Immunohistochemistry (IHC) for NUT and fluorescent in situ hybridization or reverse transcriptase-polymerase chain reaction is needed for confirmation of diagnosis.
CASE HISTORY
A 44-year-old male presented with a history of headache and dizziness since 15 days. The patient also noted mild proptosis on the right side. Magnetic resonance imaging was suggestive of a neoplastic lesion involving right sphenoid sinus. Computer tomography (CT) scan was suggestive of highly infective etiology or neoplastic etiology involving right sphenoidsinus, wing, and sella region. F 18 FDG PET-CECT was showing mild heterogeneously enhancing soft tissue density mass in right side sphenoid sinus involving the sphenoid body, sella, and cavernous region causing erosion of the wall of right sphenoid sinus, clivus, and petrous bone, suggestive of a mass lesion. We received a piecemeal biopsy.
Histologically, it was showing tumor composed of sheets of undifferentiated cells in between the areas of coagulative necrosis and inflammation. The cells have clear to eosinophilic cytoplasm, irregular nuclei, fine to vesicular chromatin, and prominent nucleoli. Mitotic figures, apoptotic bodies, and an intra tumoral inflammatory infiltrate of neutrophils are also seen [ Figure 1a and b]. 
DISCUSSION
NUT carcinoma can be seen in patients of any age (0 to 78 years), but it occurs most often in children or young adults with a median age of 22 years. [5] Most common presenting symptoms of NUT carcinoma are related to a rapidly growing mass such as epistaxis, nasal obstruction, nasal discharge, pain in sinonasal origin, and eye-related symptoms such as proptosis. Radiologically, there is frequent involvement of the orbit, cribriform plate, or cranial cavity with regional and/or distant metastases.
Histologically, these tumors are poorly differentiated, grows as nests and sheets of cells in the submucosa with necrosis and a high mitotic rate. These tumors are highly infiltrative, with a frequent invasion of nerves, vessels, and bone. It is also characterized by a strikingly monotonous cellular population of medium-sized cells with round to oval nuclei showing minimal pleomorphism. The nuclei have open chromatin and a prominent nucleolus. An intra tumoral inflammatory infiltrate of neutrophils may be seen. In general, NUT carcinoma can also demonstrate a predominantly primitive, undifferentiated appearance, but most cases exhibit foci of squamous differentiation in the form of a peculiar pattern of "abrupt" keratinization, which is previously believed to be an aggressive subtype of squamous cell carcinoma [ Figure 1 ]. NMCs are characterized by chromosomal rearrangements of the gene encoding a NUT at 15 to other genes, usually BRD4 on 19 and other protein like BRD3 creating chimeric genes that encode BRD-NUT fusion proteins. [1] On IHC, these cells are positive for NUT protein in >50% of cells, usually positive for pan-keratin, p63, p40, and CD34, and occasionally, positive for synaptophysin, p16, TTF-1, and CD99. [8] Pathologic differential diagnosis is sinonasal undifferentiated carcinoma (SNUC), poorly differentiated squamous cell carcinoma (SCC), neuroendocrine carcinoma, Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET), germ cell tumor, and olfactory neuroblastoma (ONB). NUT carcinoma is most commonly misdiagnosed as SNUC, but SNUC is negative for NUT protein and does not demonstrate histologic or immunophenotypic evidence of squamous differentiation. SCC is another consideration, but sinonasal SCC typically lacks the nuclear monotony and abrupt keratinization of NUT carcinoma and is NUT-negative. The primitive cellular appearance of NUT carcinoma and occasional CD99 positivity may cause confusion with ES/PNET. However, ES/PNET typically lacks cytokeratin and p40 immunostaining and harbors a different gene fusion (most often EWSR1-FLI1). Finally, ONB and other sinonasal small round cell tumors can enter the differential diagnosis but are easily excluded by IHC.
The diagnosis of NUT carcinoma is confirmed by demonstrating a rearrangement of NUTM1, which can be done by molecular techniques, by detecting gene fusion of NUT-BRD4, or more simply by IHC for NUT protein, which is highly sensitive (87%) and specific (100%). [1, 9] NUT immunolabeling must be present in more than 50% cells and usually demonstrates a speckled staining pattern [ Figure 2a ]. NUT carcinoma is also positive for cytokeratins and usually positive for the squamous markers p63, p40, and CK5/6. NUT carcinoma can uncommonly demonstrate neuroendocrine differentiation (synaptophysin and chromogranin) or positivity for CD99. NUT carcinoma is occasionally p16-positive but is not positive for high-risk human papilloma virus (HPV).
NUT carcinoma has the worst prognosis with a median survival of 7 months. [10] Few clinical trials are underway investigating the use of bromodomain inhibitors that target the NUTM1-BRD4 gene fusions.
CONCLUSION
NUT carcinoma is rapidly fatal and aggressive disease. Recent advances of understanding the molecular biology of NMC of 
Figure 1: (a) NUT carcinoma shows undifferentiated cells with monotonous round nuclei with open chromatin, prominent nucleoli with clear to eosinophilic cytoplasm (H and E STAIN 100×) and (b) Poorly differentiated epithelial cells with intratumoral infiltrate of neutrophils (H and E STAIN 400×)
b a BRD4-NUT fusion protein causing aberrant histone acetylation and inhibits cellular differentiation led to the use of histone deacetylase inhibitors as an additional treatment option. In addition, targeted therapy using direct-acting inhibitors of the BRD3 and BRD4 bromodomains (BET inhibitors) are also under development. Hence, it is important for pathologist to become aware of pathologic features of NMC, and subsequently, educate other clinicians about this entity, to identify effective treatment and analyze treatment outcomes.
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